AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the world’s largest drugmakers, according to people familiar with the matter.
AstraZeneca Said to Have Explored Bristol Myers Merger
AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the world’s largest drugmakers, according to people familiar with the matter.
This article was originally published by
Bloomberg Markets
and is republished here under license.
Leave a Reply